ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Liu, Zhen ^a   Lebrin, Franck ^b,c   Maring, Janita A ^a   Van Den Driesche, Sander ^b,g   Van Der Brink, Stieneke ^b   Van Dinther, Maarten ^a   Thorikay, Midory ^a   Martin, Sabrina ^c   Kobayashi, Kazuki ^a   Hawinkels, Lukas J A C ^a   Van Meeteren, Laurens A ^a   Pardali, Evangelia ^a,h   Korving, Jeroen ^b   Letarte, Michelle ^d   Arthur, Helen M ^e   Theuer, Charles ^f   Goumans, Marie José ^a   Mummery, Christine ^a,b   Ten Dijke, Peter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HUBRECHT INSTITUTE   (Netherlands)

^c PSL RESEARCH UNIVERSITY   (France)

^d UNIVERSITY OF TORONTO   (Canada)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f TRACON Pharmaceuticals   (United States)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; GELATIN; SHORT HAIRPIN RNA; VASCULOTROPIN; ENDOGLIN PROTEIN, MOUSE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HETEROZYGOTE; HUMAN; HUMAN CELL; METATARSAL BONE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; DRUG EFFECTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899862719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086273     Document Type: Article

References (64)

1. Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671-674.
2. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439. (Pubitemid 26102719)
3. Goumans MJ., Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 21: 1743-1753. (Pubitemid 34614630)
4. Gaengel K, Genove G, Armulik A, Betsholtz C. (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb.Vasc Biol 29: 630-638.
5. Bouck N, Stellmach V, Hsu SC. (1996) How tumors become angiogenic. Adv Cancer Res 69: 135-174. (Pubitemid 26274885)
6. Levy NS, Chung S, Furneaux H, Levy AP. (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423. (Pubitemid 28144735)
7. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442. (Pubitemid 26102720)
8. Mustonen T, Alitalo K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895-898.
9. Landgren E, Schiller P, Cao Y, Claesson-Welsh L. (1998) Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 16: 359-367. (Pubitemid 28052290)
10. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376: 62-66.
11. Gougos A., Letarte M. (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 141: 1925-1933.
12. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, et al. (2000) Endoglin, an ancillary TGF-β receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217: 42-53. (Pubitemid 30046798)
13. Bourdeau A, Dumont DJ, Letarte M. (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin.Invest 104: 1343-1351.
14. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, et al. (1999) Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
15. Barbara NP, Wrana JL, Letarte M. (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem 274: 584-594.
16. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, et al. (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267: 19027-19030.
17. Wieser R, Wrana JL, Massague J. (1995) GS domain mutations that constitutively activate TßR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14: 2199-2208.
18. Heldin CH, Ostman A, Ronnstrand L. (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: F79-113.
19. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF-β/ALK5 signaling. Mol Cell 12: 817-828. (Pubitemid 37352776)
20. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97: 2626-2631. (Pubitemid 30159221)
21. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, et al. (2004) Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 23: 4018-4028. (Pubitemid 39472423)
22. Guo B, Slevin M., Li C, Parameshwar S, Liu D, et al. (2004) CD105 inhibits transforming growth factor-β-Smad3 signalling. Anticancer Res 24: 1337-1345. (Pubitemid 38954647)
23. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, et al. (2005) Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex. J Cell Physiol 204: 574-584. (Pubitemid 40934653)
24. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961. (Pubitemid 46348192)
25. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, et al. (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964-972. (Pubitemid 46638511)
26. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, et al. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8: 345-351.
27. Johnson DW, Berg JN, Baldwin MA., Gallione CJ, Marondel I, et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13: 189-195.
28. Abdalla SA, Cymerman U, Rushlow D, Chen N, Stoeber GP, et al. (2005) Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia. Hum Mutat 25: 320-321.
29. Van den Driesche S, Mummery CL, Westermann CJ. (2003) Hereditary hemorrhagic telangiectasia: an update on transforming growth factor-β signaling in vasculogenesis and angiogenesis. Cardiovasc Res 58: 20-31. (Pubitemid 36351619)
30. Cho SK, Bourdeau A, Letarte M, Zuniga-Pflucker JC. (2001) Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood 98: 3635-3642.
31. Perlingeiro RC. (2007) Endoglin is required for hemangioblast and early hematopoietic development. Development 134: 3041-3048.
32. Baik J, Borges L, Magli A, Thatava T, Perlingeiro RC. (2012) Effect of endoglin overexpression during embryoid body development. Exp Hematol 40: 837-846.
33. Borges L, Iacovino M, Mayerhofer T, Koyano-Nakagawa N, Baik J, et al. (2012) A critical role for endoglin in the emergence of blood during embryonic development. Blood 119: 5417-5428.
34. Li X, Claesson-Welsh L. (2009) Embryonic stem cell models in vascular biology. J Thromb Haemost. 7 Suppl 1: 53-56.
35. Wang R, Clark R, Bautch VL. (1992) Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development 114: 303-316.
36. Pardali E, Goumans MJ, ten Dijke P. (2010) Signaling by members of the Transforming growth factor-β in vascular morphogenesis and disease. Trends Cell Biol 20: 556-567.
37. Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, et al. (1997) β1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 139: 265-278. (Pubitemid 27444097)
38. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, et al. (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1: 1623-1634. (Pubitemid 26030991)
39. Deckers M, van der Pluijm G, Dooijewaard S, Kroon M, van, Hinsbergh V, et al. (2001) Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants. Lab Invest 81: 5-15. (Pubitemid 32108635)
40. Korff T, Augustin HG. (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci 112: 3249-3258. (Pubitemid 29507205)
41. Feraud O, Cao Y, Vittet D. (2001) Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest 81: 1669-1681. (Pubitemid 33144429)
42. Feraud O, Vittet D. (2003) Murine embryonic stem cell in vitro differentiation: applications to the study of vascular development. Histol Histopathol 18: 191-199. (Pubitemid 36040460)
43. Goumans MJ, Zwijsen A, van Rooijen MA, Huylebroeck D, Roelen BA, et al. (1999) Transforming growth factor-β signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126: 3473-3483. (Pubitemid 29419506)
44. Vailhe B, Vittet D, Feige JJ. (2001) In vitro models of vasculogenesis and angiogenesis. Lab Invest 81: 439-452. (Pubitemid 32298789)
45. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, et al. (1996) Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 88: 3424-3431. (Pubitemid 26365576)
46. Park S, Dimaio TA, Liu W, Wang S, Sorenson CM, et al. (2013) Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways. J Cell Sci 126: 1392-405.
47. Nomura-Kitabayashi A, Anderson GA, Sleep G, Mena J, Karabegovic A, et al. (2009) Endoglin is dispensable for angiogenesis, but required for endocardial cushion formation in the midgestation mouse embryo. Dev Biol 335: 66-77.
48. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, et al. (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor-β1 on human vascular endothelial cells. FASEB J 14: 55-64. (Pubitemid 30051523)
49. She X, Matsuno F, Harada N, Tsai H, Seon BK. (2004) Synergy between antiendoglin (CD105) monoclonal antibodies and TGF-β in suppression of growth of human endothelial cells. Int J Cancer 108: 251-257. (Pubitemid 37541779)
50. Nolan-Stevaux O, Zhong W, Culp S, Shaffer K, Hoover J, et al. (2012) Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies. PLoS One. 7: e50920.
51. Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, et al. (2011) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem 286: 30034-30046.
52. Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, et al. (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70: 4141-4150.
53. Liu Z, Afink G, ten Dijke P. (2012) Soluble fms-like tyrosine kinase 1 and soluble Endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia. Pregnancy Hypertention 2: 358-367.
54. Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, et al. (2005) Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor-β1 with higher affinity receptors and an activated Alk1 pathway. J Biol Chem 280: 27800-27808. (Pubitemid 41076895)
55. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, et al. (2004) Defective paracrine signalling by TGF-β in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131: 6237-6247. (Pubitemid 40123935)
56. Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, et al. (2004) Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 24: 237-244. (Pubitemid 38199117)
57. nd edn. Cold Spring Harbor Laboratory Press, New York.
58. Bot PT, Hoefer IE, Sluiter JP, van Vliet P, Smit AM, et al. (2009) Increased expression of the transforming growth factor-beta signaling pathway, endoglin and early growth response-1 in stable plaques. Stroke 40: 439-447.
59. Slager HG, Freund E, Buiting AM, Feijen A, Mummery CL. (1993) Secretion of transforming growth factor-β isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation. J Cell Physiol 156: 247-256. (Pubitemid 23244086)
60. Roelen BA, Lin HY, Knezevic V, Freund E, Mummery CL. (1994) Expression of TGF-βs and their receptors during implantation and organogenesis of the mouse embryo. Dev Biol 166: 716-728.
61. Sinha S, Hoofnagle MH, Kingston PA, McCanna ME, Owens GK. (2004) Transforming growth factor-β1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 287: C1560-C1568. (Pubitemid 39507673)
62. Bajanca F, Luz M, Duxson MJ, Thorsteinsdottir S. (2004) Integrins in the mouse myotome: developmental changes and differences between the epaxial and hypaxial lineage. Dev Dyn 231: 402-415. (Pubitemid 39238067)
63. Pardali E, van der Schaft DW, Wiercinska E, Gorter A, Hogendoorn PC, et al. (2011) Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma. Oncogene 30: 334-345
64. van der Pluijm G, Lowik CW, de Groot H, Alblas MJ, van der Wee-Pals LJ, et al. (1991) Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants. J Bone Miner Res 6: 1203-1210.